Conference - Berlin, Germany
ISVHLD has a long tradition of 43 years. Initially, it focused on the discovery of the hepatitis viruses, then on the development of diagnostic procedures and vaccines as well as on understanding the pathophysiology. Today, therapies have become the focus of research and in 2015 many of the new direct antiviral agents (DAAs) against hepatitis C will be approved. Public Health becomes increasingly important. Identification of patients in need of therapy is a major challenge to make these new therapies accessible to all parts of the world. Furthermore, we still need to develop better and finite therapies for hepatitis B and need to address many more burning issues of global relevance like hepatitis D and E.
This symposium is organized every three years moving around the continents. Basic scientists and clinicians will discuss the most recent advances to combat this very important global health burden caused by all hepatitis viruses. For the first time, this symposium takes place in Germany's capital Berlin.
- Organization: MCI Deutschland
Fri, Jun 26, 2015 - Sun, Jun 28, 2015
Estrel Convention Center
Sonnenallee 225, Berlin 12057, Germany
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
